Medical management of ankylosing spondylitis

Neurosurgical Focus

Volumn 24, Issue 1, 2008, Pages

  Khalessi, Alexander A ^a   Oh, Bryan C ^a   Wang, Michael Y ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Ankylosing spondylitis; Medical management; Nonsteroidal antiinflammatory drug; Tumor necrosis factor blockade

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; IMMUNOLOGIC FACTOR;

ANKYLOSING SPONDYLITIS; HUMAN; PHYSIOTHERAPY; PRACTICE GUIDELINE; REVIEW;

ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; HUMANS; IMMUNOLOGIC FACTORS; PHYSICAL THERAPY MODALITIES; PRACTICE GUIDELINES AS TOPIC; SPONDYLITIS, ANKYLOSING;

EID: 41949096845     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/FOC/2008/24/1/E4     Document Type: Review

References (16)

1. Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, et al: Use of immunohistochemical and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheumat 38:499-505, 1995
2. Braun J, Pham T, Sieper J, Davis J, van deer Linden SJ, Dougados M, et al: International ASAS consensus statement for the use of anti-tumor necrosis factor in agents with ankylosing spondylitis. Ann Rheum Dis 62:817-824, 2003
3. Braun J, Sieper J: Ankylosing spondylitis. Lancet 369:1379-1390, 2007
4. Chen J, Liu C: Sulfasalazine for ankylosing spondylitis. Cochrane Database Syst Rev 2: CD004800, 2002
5. Chen J, Liu C, Lin J: Methotrexate for ankylosing spondylitis. Cochrane Database Syst Rev 4: CD004524, 2006
6. Dagfinrud K, Hagen KB: Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 4: CD002822, 2001
7. Hidding A, van der Linden S, Boers M, Gielen Y, de Witte L, Kester A, et al: Is group physical therapy superior to individualized therapy in ankylosing spondylitis? A randomized controlled trial. Arthritis Care Res 6:117-125, 1993
8. Khan MA: Update on spondyloarthropathies. Ann Intern Med 135:896-907, 2002
9. Kraag G, Stokes B, Groh J, Helewa A, Goldsmith C: The effects of comprehensive home physiotherapy dnd supervision on patients with ankylosing spondylitis - a randomized controlled trial. J Rheumatol 17:228-233, 1990
10. Krauth C, Rieger J, Bönisch A, Ehlebracht-König I: [Costs and benefits of an education program for patients with ankylosing spondylitis as part of an inpatient rehabilitation program - study design and first results. Z Rheumatol 62:114-116, 2003 (Ger).
11. Lim HJ, Moon Y, Lee MS: Effects of home-based daily exercise therapy on joint mobility, daily, activity, pain, and depression in patients with ankylosing spondylitis. Rheumatol Int 25:225-229, 2005
12. Maksymowych WP, Jhangri GS, Fitzgerald AA, LeClerq S, Chiu P, Yan A, et al: A six-month randomized, controlled, doubleblind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. Arthritis Rheumatol 46:766-773, 2002
13. Ward MM, Kuzis S: Medication toxicity among patients with ankylosing spondylitis. Arthritis Rheum 47:234-241, 2002
14. Zochling J, Maxwell L, Beardmore J, Boonen A: TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Systemic Rev 3: CD005468, 2005.
15. Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC Jr, Dijkmans B, et al: ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65:442-452, 2006
16. Zochling J, van der Heijde D, Dougados M, Braun J: Current evidence for the management of ankylosing spondylitis: a systemic literature review of the ASAS/EULAR management recommendations in ankylosing spondylitis. Ann Rheum Dis 65:423-432, 2006